A review of the construct of mild cognitive impairment: General aspects;Revisión del constructo deterioro cognitivo leve: Aspectos generales

Revista de Neurologia

Volumn 52, Issue 5, 2011, Pages 300-305

  Sánchez Rodríguez, Juan Luis ^a   Torrellas Morales, Clara ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Alzheimer's disease; Dementias; Markers of dementia; Mild cognitive impairment; Neuropsychological examination; Neuropsychology

Indexed keywords

ALZHEIMER DISEASE; DEMENTIA; DIAGNOSTIC TEST; DISEASE COURSE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; REVIEW; CLASSIFICATION; COGNITIVE DEFECT; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; HUMANS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79952338873     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5205.2010245     Document Type: Review

References (41)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8. (Pubitemid 29120227)
2. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41: 1006-9.
3. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-9. (Pubitemid 12051593)
4. Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003; 2: 646-53. (Pubitemid 37361768)
5. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-92. (Pubitemid 33143977)
6. Nelson AP, O'Connor MG. Mild cognitive impairment: a neuropsychological perspective. CNS Spectr 2008; 13: 56-64. (Pubitemid 351224283)
7. Agüera LF, Cervilla JA, Martín M. Psiquiatría geriátrica. Barcelona: Elsevier-Masson; 2006.
8. Beinhoff U, Tumani H, Brettschneider J, Bittner D, Riepe MW. Gender-specificities in Alzheimer's disease and mild cognitive impairment. J Neurol 2008; 255: 117-22.
9. Íñiguez J. El deterioro cognitivo leve (2): factores predictivos y abordaje terapéutico. Informes Portal Mayores 2006; 46: 1-20.
10. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397-405. (Pubitemid 32217456)
11. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228-34. (Pubitemid 43238346)
12. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-94. (Pubitemid 39222988)
13. Prodan CI, Ross ED, Vincent AS, Dale GL. Coated-platelets are higher in amnestic versus nonamnestic patients with mild cognitive impairment. Alzheimer Dis Assoc Disord 2007; 21: 259-61. (Pubitemid 47367979)
14. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916-24. (Pubitemid 44188484)
15. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6: 63-8.
16. Bidzan L, Pachalska M, Bidzan M. Predictors of clinical outcome in MCI. Med Sci Monit 2007; 13: 398-405.
17. Molinuelo JL, Peña-Casanova J. Guía oficial para la práctica clínica en demencias: conceptos, criterios y recomendaciones. Barcelona: Thomson Reuters; 2009.
18. Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, et al. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 2008; 70: 2020-1.
19. Peña-Casanova J, Gramunt-Fombuena N, Gich J. Test neuropsicológicos. Barcelona: Masson; 2004.
20. El Médico Interactivo. Aula acreditada. URL: http://www.medynet. com/elmedico/aula. [12.06.2000]
21. Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry 2006; 189: 399-404. (Pubitemid 44683170)
22. Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008; 63: 494-506. (Pubitemid 351614715)
23. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198-205. (Pubitemid 34779177)
24. Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K, et al. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 2008; 4: 38-48.
25. Monge-Argilés JA, Sánchez-Payá J, Muñoz-Ruiz C, Pampliega-Pérez A, Montoya-Gutiérrez J, Leiva-Santana C. Biomarcadores en el líquido cefalorraquídeo de pacientes con deterioro cognitivo leve: metaanálisis de su capacidad predictiva para el diagnóstico de la enfermedad de Alzheimer. Rev Neurol 2010; 50: 193-200.
26. Rosenberg PB, Johnston D, Lyketsos CG. A clinical approach to mild cognitive impairment. Am J Psychiatry 2006; 163: 1884-90. (Pubitemid 44807779)
27. Otero JL, Scheitler LF. Las fronteras entre el envejecimiento cognitivo normal y la enfermedad de Alzheimer. El concepto de deterioro cognitivo leve. Revista Médica del Uruguay 2003; 19: 4-13.
28. Baquero M, Blasco R, Campos-García A, Garcés M, Fages EM, Andreu-Catalá M. Estudio descriptivo de los trastornos conductuales en el deterioro cognitivo leve. Rev Neurol 2006; 38: 323-6. (Pubitemid 38418850)
29. Copeland MP, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, et al. Psychiatric symptomatology and prodromal Alzheimer's disease. Alzheimer Dis Assoc Disord 2003; 17: 1-8. (Pubitemid 36288240)
30. Modrego PJ, Fernández J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. Arch Neurol 2004; 61: 1290-3. (Pubitemid 39062687)
31. Reyes-Figueroa JC, Rosich-Estragó M, Bordas-Buera E, Gaviria-Gómez AM, Vilella-Cuadrada E, Labad-Alquézar A. Síntomas psicológicos y conductuales como factores de progresión a demencia tipo Alzheimer en el deterioro cognitivo leve. Rev Neurol 2010; 50: 653-60.
32. Houde M, Bergman H, Whitehead V, Chertkow H. A predictive depression pattern in mild cognitive impairment. Int J Geriatr Psychiatry 2008; 23: 1028-33.
33. Panza F, Frisardi V, Santamato A, Capurso C, D'Introno A, Colacicco AM, et al. Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? J Rehabil Med 2008; 41: 293-4.
34. Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, et al. Randomized, placebo-controlled, doubleblind clinical trial of setraline in the treatment of depression complication Alzheimer's disease: initial results from the depression in Alzheimer's disease study. Am J Psychiatry 2000; 157: 1686-9.
35. Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 2008; 25: 115-26. (Pubitemid 351196123)
36. Robert PH, Berr C, Volteau M, Bertogliati-Fileau C, Benoit M, Guerin O, et al. Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry 2008, 16: 770-6.
37. Palmer K, Berger AK, Monasterio R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68: 1596-602. (Pubitemid 46717984)
38. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997; 277: 813-7.
39. Sánchez JL, Rodríguez M, Carro J. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 113-22. (Pubitemid 34632579)
40. Valenzuela MJ. Brain reserve and the prevention of dementia. Curr Opin Psychiatry 2008; 21: 296-302. (Pubitemid 351489352)
41. Stern Y. Cognitive reserve. Neuropsychologia 2009; 47: 2015-28.